Features A - Z
View Features alphabetically- A bitter pill to swallow – the excipient approval process
- A common accord – harmonised data exchange
- A contract, not a marriage – building pharma partnerships
- A fully integrated future - pharmaceutical manufacturing processes
- A matter of degrees – cold chain management
- A new chapter – examining new cross-contamination guidelines
- A problem shared – utilising clinical trials data
- A solution for poor water solubility
- A visible difference: clinical packaging
- A vital cog in the machine
- Adapt and thrive – understanding adaptive clinical trials
- Adverse reactions: drug safety
- Ahead of the game – risk management in clinical trial supply chains
- Air cargo transportation: on the right path
- All together now – harmonising clinical trial regulation
- An inspector calls – maintaining good manufacturing practices
- Analyse this – the rise of Raman spectroscopy
- Automatic improvement – optimising manufacturing processes
- Behind the healthy cover of supply chain security
- Better together - rapid sourcing of quality drugs
- Better together
- Better together – working with CMOs
- Birth of cyber-collaboration
- Blanket decisions – hot trends in the cold chain
- Boxing clever with pharmaceutical packaging
- Brave new world – the risks and rewards of emerging markets
- Buying niche and new businesses
- Caught in the net with packaging protection
- Central to success? Reliable data in trials
- Chain reaction: safety in logistics
- Changing trends in early-stage clinical trials
- Check the forecast: supply challenges
- Choose wisely: selecting the right CRO
- Cold comfort - Cloud-based temperature-monitoring solutions
- Cold hard facts of freeze-drying drugs
- Collaboratively speaking – comparator supply
- Combined effort – launching combination products
- Coming together in hard times: biotech funding
- Common people – a single view of process data
- Comparator wisdom – analysing comparator sourcing
- The complete guide through the pharma product chain
- Contractually yours – quality contract manufacturing
- Controlled-release drugs: ready for take-off
- Cool gadgets for the cold chain
- Cool operator
- The cost of creativity
- Cost of a deep cut
- Critical factors in CRO contracting
- Crystal clear: production of co-crystals
- Cut costs, not quality: outsourcing in clinical trials
- Dangerous liaisons
- Delivering the goods: drug delivery in a competitive market
- Design on trial – immune-oncology challenges
- Designs on packaging sustainability
- Diagnosis merger – examining the mega M&A trend
- Digital leap into the pharmaceutical production line
- Digitally speaking – the future of pharmaceutical R&D
- Don’t skimp on quality – maximising quality to reduce costs
- Drug trials: publish and be damned
- Eastern Europe comes in from the cold
- Eastern promise - the Chinese pharmas’ market
- eCDT’s benefit performance
- Elegant simplicity – single-dose disposable inhalers
- Emerging markets come in from the cold
- Energise the chain – Harvey Rubin
- Erase rubber risk
- Excipients: pharma’s silent partners
- Extreme measures – a robust vaccine supply chain
- Fail to plan, plan to fail – the timely delivery of drug supply
- False moves – purging the market of counterfeit drugs
- Final analysis - strategies for POC trials
- Find your balance – bridging internal capacity gaps
- Focus on your recruitment practices
- Follow the leader: biopharma growth in Latin America
- Follow the trail to forgery – supply chain safety
- Freedom of choice – choosing the correct vendor
- Freight expectations – GDP guidelines and the CEIV Pharma programme
- From molecule to medicine - peptide and protein drugs
- Future perfect: identity security in global collaboration
- Future perfect – reshaping supply chain strategy
- Get on board – transporting pharmaceuticals by sea
- Get smart – next-generation pharmaceutical packaging
- Get the programme started – cost-effective supply chain security
- Go the extra mile – shipment temperature monitoring
- A good deal better: pharmaceutical mergers and acquisitions
- Got your number: combating counterfeiting across Europe
- Great expectations in new excipients
- Greener sleeves – packaging sustainability in the pharma sector
- Pack mentality – clinical trial packaging
- Pack to the future – medical packaging for the elderly
- Parenteral control - challenges of formulating novel excipients
- Partners on the front lines – emergency planning and collaboration
- Partnerships that ease pain
- Patient approach – tailoring therapies to individual needs
- Pep talk
- Pep talk – manufacturing peptide tablets
- Personalised supply chain – the changing face of clinical trials
- Pharma cold chain: a calculated risk
- Pharma deals on the rise
- Pharma industry must unite in fight against cybercrime
- Pharmaceutical outsourcing: building a model
- Pharma’s emerging focus
- Pharma’s emerging markets
- Phone it in – Roma Maguire discusses the eSMART study
- Picture perfect: imaging in therapeutic drug development
- Play it cool in the pharma cold chain
- Positive reaction: public opinion of adjuvants
- Power of OTC drugs – the over-the-counter revolution
- Power tools – biomedical informatics
- Print your own medicine – the evolution of 3D printing
- Privacy vs progress: patient confidentiality in personalised medicine
- Problem dissolved? – ensuring improved bioavailability
- Profitable packaging – reducing cost without compromising quality
- Protected links – safeguarding the supply chain
- Push for paperless clinical trials
- Put patients first – increasing awareness of clinical trials
- Safe and stable – the importance of stability data
- Safe trip – standardising insulated shipping containers
- Safety conscious – the role of RMPs in pharmacovigilance
- Same difference: biosimilars market growth
- Scaling the pharmaceutical patent cliff
- Second chance saloon - the sale of unused comparators
- Second skin – wearable drug delivery
- Shaping the future of clinical data management
- Slow and steady wins the race
- Small companies with big perks
- Small impact, big rewards: global pharma vs climate change
- Smart thinking: data management
- Socially adverse – inside the Web-RADR project
- Sourcing comparator drugs: the tactical approach
- Space to grow – treating Type 2 diabetes
- Special drug delivery
- Spread too thin?
- Stop, thief! – pharmaceutical shipment security
- The strongest link: ensuring product security in the supply chain
- eCTD submissions made simple
- Supply-chain lockdown – serialisation regulation
- Suspended solutions for solubility
- Sustainable growth: pharma goes green
- Swap the runway for the waves – the ocean-going supply chain
- Take a deep breath – inhalable drug delivery
- Take five: significant pharma industry deals in Q2/Q3
- The bottom line – the global therapeutics market for irritable bowel syndrome
- The changing face of product identity
- The changing role of the data manager
- The chill factor – cold chain strategies
- The cold chain: ensuring a smooth ride
- The cost of new cures – inside the NCE market
- The devil’s in the data – clinical data integration
- The dust disruption – ensuring sterile clean rooms
- The future is biological - high-concentration liquid formulations
- The game changers: WPF awards 2013
- The growing case for reusable packaging
- The human factor – pharmaceutical packaging
- The importance of being compliant – packaging and labelling processes
- The necessity of quality control – examining CRT technology
- The need for lean
- The new administration – prefilled syringes and auto-injectors
- The new cool – the changing face of pharma transportation
- The quicker the better – air freight and temperature control
- The rewards of risk management – de-risking globalised supply chains
- The sky’s the limit – cloud computing for clinical trials
- The sprinkle formula – the viability of minitablets
- The tactical game of comparators - logistical and regulatory hurdles
- Third-party people – alternatives to the contract manufacturing model
- Third-party people – collaborative diabetes drug development
- Time to act – challenging packaging conventions
- Tipping point – point-of-care diagnostics
- Top ten generic companies
- Top ten generic pharma
- Top ten global pharma
- Track changes – serialisation best practice
- Tracked and traced – end-to-end supply chain visibility
- Tracking all over the world – serialising medical products
- Turn the page – electronic PROs
